Keeping You Updated
PharmaVentures acted as advisor for sale of PhotoBioChem, N.V. patent assets to SpectraCure, AB
Oxford, UK, April 7, 2008
PharmaVentures announced today that it had acted as an advisor and broker to PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden.
Dr Fintan Walton, CEO, PharmaVentures said, “We were delighted to bring another successful outcome for one of our clients. We were proud to act as advisors and facilitators to PhotoBioChem in the divestment of its patent portfolio”.
About PharmaVentures
PharmaVentures (http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making. The Company's core business is the provision of tailored transaction advisory services to the Life Science industry. PharmaVentures is based in Oxford, UK, and employs over 35 people. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporations.
- ends -
Note to Editors
PharmaVentures Limited (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It has considerable experience and expertise in the field of tangible and intangible transactions, providing advice at both a strategic level, as well as acting as advisor and broker at an implementation level. Its transactional experience includes licensing, joint ventures, mergers, acquisitions and divestments. Its clients are worldwide, including Europe, the USA and AsiaPacific. Clients range from start-ups to global pharmaceutical corporations, diversified industrial corporations, investment houses and government bodies. Its subsidiary PharmaTelevision produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com).
Now in its 18th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.